Evidence map›Paper›PMID 24501197›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Three tapasin docking sites in TAP cooperate to facilitate transporter stabilization and heterodimerization.

Ralf M Leonhardt, Parwiz Abrahimi, Susan M Mitchell, Peter Cresswell

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Dynamic interactome of the MHC I peptide loading complex in human dendritic cells.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Moving the Cellular Peptidome by Transporters.Frontiers in cell and developmental biology · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ralf M LeonhardtHoward Hughes Medical Institute, New Haven, CT 06520;
Parwiz Abrahimi
Susan M Mitchell
Peter Cresswell
Yale University · USHoward Hughes Medical Institute · US

Funding

Yale SPORE in Skin CancerP50CA121974 · NCI · YALE UNIVERSITY · PI DAVID F STERN · 2006 to 2026
$43.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Quality Control of MHC Class I Restricted Antigen ProcessingR01AI097206 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2012 to 2020
$4.1M
ROLE OF ENDOCYTOSIS IN CELL RECOGNITIONR37AI023081 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2001 to 2010
$3.4M
Howard Hughes Medical InstituteNCI NIH HHS 5P50 CA121974NCI NIH HHS P50 CA121974NIAID NIH HHS R01 AI097206NIAID NIH HHS R01-AI097206NIAID NIH HHS R37 AI023081NIAID NIH HHS R37-AI023081NIGMS NIH HHS NIH MSTP TG T32GM07205NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

The TAP translocates peptide Ags into the lumen of the endoplasmic reticulum for loading onto MHC class I molecules. MHC class I acquires its peptide cargo in the peptide loading complex, an oligomeric complex that the chaperone tapasin organizes by bridging TAP to MHC class I and recruiting accessory molecules such as ERp57 and calreticulin. Three tapasin binding sites on TAP have been described, two of which are located in the N-terminal domains of TAP1 and TAP2. The third binding site is present in the core transmembrane (TM) domain of TAP1 and is used only by the unassembled subunits. Tapasin is required to promote TAP stability, but through which binding site(s) it is acting is unknown. In particular, the role of tapasin binding to the core TM domain of TAP1 single chains is mysterious because this interaction is lost upon TAP2 association. In this study, we map the respective binding site in TAP1 to the polar face of the amphipathic TM helix TM9 and identify key residues that are essential to establish the interaction. We find that this interaction is dispensable for the peptide transport function but essential to achieve full stability of human TAP1. The interaction is also required for proper heterodimerization of the transporter. Based on similar results obtained using TAP mutants that lack tapasin binding to either N-terminal domain, we conclude that all three tapasin-binding sites in TAP cooperate to achieve high transporter stability and efficient heterodimerization.

Indexed as

ATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 2ATP Binding Cassette Transporter, Subfamily B, Member 3Binding SitesCalreticulinCell Line, TumorHistocompatibility Antigens Class IHumansMembrane Transport ProteinsProtein Disulfide-IsomerasesProtein MultimerizationProtein StabilityProtein Structure, SecondaryATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 2ATP Binding Cassette Transporter, Subfamily B, Member 3CalreticulinCALR protein, humanHistocompatibility Antigens Class IMembrane Transport ProteinsPDIA3 protein, humanProtein Disulfide-IsomerasesTAP1 protein, humanTAP2 protein, humantapasin

Identifiers

PMID24501197
PMCPMC3943870
OpenAlexW2134888690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.